Please login or register first to view this content.
Metabolic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Recall of Sodium Bicarbonate Injection Due to Vial Breakage Expanded
Semaglutide Reduces BMI More Than Lifestyle Changes in Teens With Obesity
October 2022 Recap: Drug Pipeline Updates
Joint Statement Issued for Metabolic and Bariatric Surgery
Endoscopic Sleeve Gastroplasty Safe and Efficacious for Class III Obesity
Alvelestat Gets Fast Track Status for AATD-Associated Lung Disease
AAP: Children’s Body Mass Index Rose During Pandemic
Reports of Vial Breakage Prompt Recall of Sodium Bicarbonate Injection
September 2022 Recap: Drug Pipeline Updates
Oxlumo Indication Expanded to Include Patients With Advanced PH1
Tirzepatide Gets Fast Track Status for Treatment of Obesity
Leniolisib Gets Priority Review for Activated Phosphoinositide 3-Kinase Delta Syndrome
Semaglutide Reduces 10-Year Risk for T2D in Obese Persons
Skysona Gets Accelerated Approval for Early, Active Cerebral Adrenoleukodystrophy
Patient-Doctor Disagreements More Likely in Overweight Patients
FDA to Review Velmanase Alfa for Alpha-Mannosidosis
August 2022: Notable Drug Approvals
Orkambi Indication Expanded to Include More Children With Cystic Fibrosis
